| 2026-06-01 | 8-K | 10.1 | Executive Employment Agreement between West Pharmaceutical Services, Inc. and Michel Lagarde dated May 31, 2026. |
|---|
| 2026-02-17 | 10-K | 10.27 | Form of 2025 Restricted Stock Unit Award issued under the 2016 Amended and Restated Omnibus Incentive Compensation Plan. |
|---|
| 2026-02-17 | 10-K | 10.26 | Form of 2025 Stock Option Award issued under the 2016 Amended and Restated Omnibus Incentive Compensation Plan. |
|---|
| 2026-02-17 | 10-K | 10.25 | Form of 2025 Performance Stock Unit (PSU) Award issued under the 2016 Amended and Restated Omnibus Incentive Compensation Plan. |
|---|
| 2025-07-21 | 8-K | 10.1 | Offer Letter, dated July 11, 2025, between West Pharmaceutical Services, Inc. and Robert McMahon. |
|---|
| 2025-05-12 | 8-K/A | 10.15 | Amended and Restated 2016 Omnibus Incentive Compensation Plan |
|---|
| 2025-04-24 | 10-Q | 10.3 | Form of 2025 Stock Option Agreement, issued pursuant to the 2016 Omnibus Incentive Compensation Plan. |
|---|
| 2025-04-24 | 10-Q | 10.2 | Form of 2025 Performance Stock Unit Agreement, issued pursuant to the 2016 Omnibus Incentive Compensation Plan. |
|---|
| 2025-04-24 | 10-Q | 10.1 | Form of 2025 Restricted Stock Unit Agreement, issued pursuant to the 2016 Omnibus Incentive Compensation Plan. |
|---|
| 2025-04-24 | 8-K | 10.1 | Employment Agreement, dated March 31, 2025 between West Pharmaceutical Services, Inc. and Shane Campbell. |
|---|
| 2025-04-14 | 8-K | 10.1 | Separation Agreement and Release, dated as of April 9, 2025 |
|---|
| 2024-07-08 | 8-K | 10.1 | Third Amendment and Incremental Facility Amendment, dated as of July 2, 2024, among the Company, as borrower’s representative, each of the lenders party thereto and Bank of America, N.A., as the administrative agent. |
|---|
| 2024-04-25 | 10-Q | 10.1 | Form of 2024 Stock Option Agreement, Performance Stock Unit Agreement and Restricted Stock Unit Agreement, issued pursuant to the 2016 Omnibus Incentive Compensation Plan |
|---|
| 2024-02-20 | 10-K | 10.42 | Securities Trading Policy, dated and effective April 15, 2021, and Section 10b5-1 Approved Trading Plan Guidelines, dated and effective February 27, 2023 |
|---|
| 2024-02-20 | 10-K | 10.41 | Executive Officer Incentive-based Compensation Recovery Policy, dated and effective October 2, 2023 |
|---|
| 2024-02-20 | 10-K | 10.14 | Non-Qualified Deferred Compensation Plan for Designated Employees, as amended and restated effective January 1, 2024 |
|---|
| 2023-11-30 | 8-K | 10.40 | Amendment No. 1 to Global Master Supply Agreement, entered into on November 27, 2023, and effective from January 1, 2024 through December 31, 2028, between West Pharmaceutical Services, Inc. and ExxonMobil Product Solutions Company. |
|---|
| 2022-04-01 | 8-K | 10.1 | Credit Agreement Second Amendment and Joinder and Assumption Agreement, dated as of March 31, 2022, between West, certain of its subsidiaries, the lenders party thereto from time-to-time, Bank of America, N.A., as Administrative Agent, Swing Line Lender and an Issuing Lender; BOFA Securities, Inc., Wells Fargo Securities, LLC, U.S. Bank National Association, and JPMorgan Chase Bank, N.A., as Joint Lead Arrangers and Joint Bookrunners, and Wells Fargo Bank, National Association, U.S. Bank National Association, and JPMorgan Chase Bank, N.A., as Co-Syndication Agents. |
|---|
| 2022-02-22 | 10-K | 10.10 | Employment Agreement dated February 8, 2018, between Silji Abraham and us. |
|---|
| 2022-02-22 | 10-K | 10.9 | Employment Agreement dated November 4, 2020, between Kimberly MacKay and us. |
|---|
| 2021-10-28 | 10-Q | 10.1 | LIBOR Transition Amendment to the Credit Agreement, dated as of March 28, 2019, between West, each of the lenders party thereto from time to time, and Bank of America, N.A |
|---|
| 2021-05-06 | 8-K | 10.36 | 2016 Omnibus Incentive Compensation Plan amendment dated, May 4, 2021. |
|---|
| 2020-10-23 | 10-Q | 10.10 | Non-Qualified Deferred Compensation Plan for Designated Employees, as amended and restated effective January 1, 2020. |
|---|
| 2020-02-24 | 10-K | 10.2 | First Amendment and Incremental Facility Amendment, dated as of December 30, 2019, between West, each of the lenders party thereto from time to time, and Bank of America, N.A., as Administrative Agent. |
|---|
| 2020-01-16 | 8-K | 10.1 | Global Master Supply Agreement, entered into on January 10, 2020, and effective from January 1, 2019 through December 31, 2023, between West Pharmaceutical Services, Inc. and ExxonMobil Chemical Company. |
|---|
| 2019-10-16 | 8-K | 10.1 | Amendment Agreement, dated as of October 15, 2019, between West Pharmaceutical Services, Inc. and Daikyo Seiko, Ltd. |
|---|
| 2019-05-08 | 10-Q | 10.3 | Form of 2019 Stock Option Award issued under the 2016 Omnibus Incentive Compensation Plan. |
|---|
| 2019-05-08 | 10-Q | 10.2 | Form of 2019 Performance Stock Unit (PSU) Award issued under the 2016 Omnibus Incentive Compensation Plan. |
|---|
| 2019-04-01 | 8-K | 10.1 | Credit Agreement, dated as of March 28, 2019, between West, certain of its subsidiaries, the lenders party thereto from time to time, Bank of America, N.A., as Administrative Agent, Swing Line Lender and an Issuing Lender; Merrill Lynch, Pierce, Fenner & Smith Incorporated, Wells Fargo Securities, LLC, MUFG Bank, Ltd., and JPMorgan Chase Bank, N.A., as Joint Lead Arrangers and Joint Bookrunners, and Wells Fargo Bank, National Association, MUFG Bank, Ltd., and JPMorgan Chase Bank, N.A., as Co-Syndication Agents. |
|---|
| 2019-02-28 | 10-K | 10.10 | Non-Qualified Deferred Compensation Plan for Designated Employees, as amended and restated effective December 1, 2018. |
|---|
| 2018-07-31 | 10-Q | 10.2 | Amended Agreement, dated and effective July 2, 2018, between Daikyo Seiko, Ltd. and us. |
|---|
| 2018-06-21 | 8-K | 10.1 | Employment Agreement, dated May 29, 2018, between West Pharmaceutical Services, Inc. and Bernard J. Birkett. |
|---|
| 2017-10-31 | 10-Q | 10.1 | Form of Change-in-Control Agreement between us and certain of our executive officers. |
|---|
| 2017-02-28 | 10-K | 10.40 | TECHNOLOGY EXCHANGE AND CROSSLICENSE AGREEMENT |
|---|
| 2017-02-28 | 10-K | 10.39 | DISTRIBUTORSHIP AGREEMENT |
|---|
| 2016-10-31 | 10-Q | 10.2 | Agreement, dated August 16, 2016 to amend Agreement by and between the Goodyear Tire & Rubber Company and us. (2) |
|---|
| 2016-10-31 | 10-Q | 10.1 | Employment Agreement, dated August 28, 2016 between David Montecalvo and us. |
|---|
| 2016-08-01 | 10-Q | 10.1 | Amendment to Global Supply Agreement dated March 17, 2016 by and between ExxonMobil Chemical Company and us. (2) |
|---|
| 2015-11-02 | 10-Q | 10.1 | First Amendment to Credit Agreement, dated as of September 4, 2015, by and among West, certain of its subsidiaries, the several banks and other financial institutions party thereto, and PNC Bank, National Association, as administrative agent for the Lenders. |
|---|
| 2015-10-19 | 8-K | 10.1 | Credit Agreement, dated as of October 15, 2015, between West, certain of its subsidiaries, the lenders party thereto from time to time, PNC Bank, National Association, as Administrative Agent, Bank of America, N.A., Wells Fargo Bank, National Association and U.S. Bank National Association, as Syndication Agents, Citizens Bank of Pennsylvania and TD Bank, N.A., as Documentation Agents, and JPMorgan Chase Bank, N.A., HSBC Bank USA, National Association, and Northern Trust Company. PNC Capital Markets, LLC, was Sole Lead Arranger and Sole Bookrunner. |
|---|
| 2015-08-03 | 10-Q | 10.2 | 2015 Long-Term Incentive Plan Award, dated as of June 30, 2015, between us and Donald E. Morel, Jr. |
|---|
| 2015-08-03 | 10-Q | 10.1 | Retirement Separation Agreement, dated as of June 30, 2015, between us and Donald E. Morel, Jr., Ph.D., is incorporated by reference from our Form 8-K dated July 1, 2015. |
|---|
| 2015-07-01 | 8-K | 10.1 | Retirement Separation Agreement, dated June 30, 2015, between West Pharmaceutical Services, Inc. and Donald E. Morel, Jr., Ph.D. |
|---|
| 2015-04-30 | 8-K | 10.2 | Sign-On Retention Award Notice, dated April 24, 2015, from West Pharmaceutical Services, Inc. to Eric M. Green. |
|---|
| 2015-04-30 | 8-K | 10.1 | Indemnification Agreement, dated April 24, 2015, between West Pharmaceutical Services, Inc. and Eric M. Green. |
|---|
| 2015-04-15 | 8-K | 10.1 | Employment Agreement, dated April 13, 2015, between West Pharmaceutical Services, Inc. and Eric M. Green. |
|---|
| 2015-02-25 | 10-K | 10.15 | ex1015separationagreement.htm |
|---|
| 2014-08-15 | 8-K | 10.1 | GLOBAL SUPPLY AGREEMENT |
|---|
| 2014-08-01 | 10-Q | 10.1 | EX 10.1 2014 RSU AWARD LETTER |
|---|
| 2014-05-08 | 10-Q | 10.1 | EXH 10.1 2014 LTIP AWARD LETTER |
|---|
| 2014-02-27 | 10-K | 10.26 | EXHIBIT 10.26 NON-QUALIFIED DEFERRED COMPENSATION PLAN |
|---|
| 2014-02-27 | 10-K | 10.18 | EXHIBIT 10.18 CHANGE-IN-CONTROL AGREEMENT |
|---|
| 2014-02-27 | 10-K | 10.17 | EXHIBIT 10.17 CHANGE-IN-CONTROL AGREEMENT |
|---|
| 2014-02-27 | 10-K | 10.16 | EXHIBIT 10.16 CHANGE-IN-CONTROL AGREEMENT |
|---|
| 2013-02-06 | 8-K | 10.1 | First Amendment to Credit Agreement dated as of February 1, 2013 among West Pharmaceutical Services, Inc., certain of its subsidiaries, the several banks and other financial institutions party thereto, and PNC Bank, National Association, as administrative agent. |
|---|
| 2012-07-10 | 8-K | 10.1 | NOTE PURCHASE AGREEMENT |
|---|
| 2012-05-03 | 8-K | 10.1 | CREDIT AGREEMENT |
|---|
| 2012-02-29 | 10-K | 10.12 | CHANGE IN CONTROL AGREEMENT |
|---|
| 2011-07-01 | 8-K | 10.1 | GLOBAL SUPPLY AGREEMENT |
|---|
| 2011-06-09 | 8-K | 10.2 | EXHIBIT 10.2 - SECURITY AGREEMENT |
|---|
| 2011-06-09 | 8-K | 10.1 | EXHIBIT 10.1 - CREDIT AGREEMENT |
|---|
| 2011-05-06 | 8-K | 10.1 | 2011 OMNIBUS INCENTIVE COMPENSATION PLAN |
|---|
| 2011-02-28 | 10-K | 10.2 | NOTICE OF EXERCISE OF OPTION |
|---|
| 2010-12-22 | 8-K | 10.1 | Lease Agreement by and between 530 Regency Drive Associates, L.P., and West Pharmaceutical Services, Inc. dated December 17, 2010. |
|---|
| 2010-06-10 | 8-K | 10.1 | Credit Agreement, dated as of June 4, 2010, between West, certain of its subsidiaries, the lenders party thereto from time to time, PNC Bank, National Association, as Administrative Agent, Bank of America, N.A. and Wells Fargo Bank, National Association, as Syndication Agents, Citizens Bank of Pennsylvania, as Documentation Agent, and PNC Capital Markets, LLC, as Lead Arranger. |
|---|
| 2010-02-25 | 10-K | 10.13 | SEVERENCE LETTER AGREEMENT |
|---|
| 2009-11-04 | 10-Q | 10.1 | 2009 SUPPLEMENTAL LTI AWARD |
|---|
| 2009-05-06 | 10-Q | 10.1 | First Agreement to Amend to Agreement between the Company and The Goodyear Tire & Rubber Company.2 |
|---|
| 2009-02-27 | 10-K | 10.52 | AMENDMENT #2 TO LETTER |
|---|
| 2009-02-27 | 10-K | 10.41 | exhibit1041.htm |
|---|
| 2009-02-27 | 10-K | 10.19 | NON-QUALIFIED DEFERRED COMPENSATION PLAN |
|---|
| 2009-02-27 | 10-K | 10.18 | NON-QUALIFIED DEFERRED COMPENSATION PLAN |
|---|
| 2009-02-27 | 10-K | 10.17 | SUPPLEMENTAL EMPLOYEES’ RETIREMENT PLAN |
|---|
| 2009-02-27 | 10-K | 10.15 | AMENDMENT #1 TO EMPLOYMENT |
|---|
| 2009-02-27 | 10-K | 10.9 | Officers Listed Below. Each agreement is substantially identical in |
|---|
| 2009-02-27 | 10-K | 10.8 | FORM OF AMENDMENT #2 TO SECOND |
|---|
| 2009-01-06 | 8-K | 10.1 | INDEMNIFICATION AGREEMENT |
|---|